Clinical Trials
9
Active:0
Completed:8
Trial Phases
2 Phases
Phase 4:1
Not Applicable:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)β’ Click on a phase to view related trials
Not Applicable
4 (80.0%)Phase 4
1 (20.0%)The Risk Factors of Symptomatic Gallbladder Stone: Age-Sex Matched Case-control Study Performed in Single Institute
Completed
- Conditions
- Gallstone
- First Posted Date
- 2016-06-21
- Last Posted Date
- 2016-06-21
- Lead Sponsor
- Cheju Halla General Hospital
- Target Recruit Count
- 342
- Registration Number
- NCT02808546
Nerve Stimulator Versus Ultrasound-guided Infraclavicular Block
Not Applicable
Completed
- Conditions
- Pain
- First Posted Date
- 2015-01-26
- Last Posted Date
- 2016-01-28
- Lead Sponsor
- Cheju Halla General Hospital
- Target Recruit Count
- 44
- Registration Number
- NCT02344615
- Locations
- π°π·
Cheju Halla General Hopsital, Jeju, Jeju self-governing province, Korea, Republic of
Nerve Stimulator Versus Ultrasound-guided Interscalene Block for Shoulder Surgery
Not Applicable
Completed
- Conditions
- Pain
- First Posted Date
- 2015-01-21
- Last Posted Date
- 2017-07-17
- Lead Sponsor
- Cheju Halla General Hospital
- Target Recruit Count
- 53
- Registration Number
- NCT02342873
- Locations
- π°π·
Cheju Halla General Hopsital, Jeju-si, Jeju special governing province, Korea, Republic of
Alcohol Consumption and Gallbladder Cancer
Completed
- Conditions
- Gallbladder Cancer
- First Posted Date
- 2014-12-30
- Last Posted Date
- 2014-12-30
- Lead Sponsor
- Cheju Halla General Hospital
- Target Recruit Count
- 156
- Registration Number
- NCT02326948
- Locations
- π°π·
Cheju Halla General Hopsital, Jeju-si, Jeju special governing province, Korea, Republic of
Lidocaine Spray on an Endoscope to Improve Tolerance to Endoscopy
Completed
- Conditions
- C.Medical Procedure; Digestive SystemDisorder of Upper Gastrointestinal TractTolerance
- Interventions
- Drug: Case Group
- First Posted Date
- 2014-12-04
- Last Posted Date
- 2015-01-13
- Lead Sponsor
- Cheju Halla General Hospital
- Target Recruit Count
- 497
- Registration Number
- NCT02307773
- Locations
- π°π·
Digestive Disease Center and Department of Internal Medicine, Cheju Halla General Hospital, Jeju-si, Jeju Special Self-Governing Province, Korea, Republic of
- Prev
- 1
- 2
- Next
News
No news found